AI 摘要
我们查看了 semi daonil 的 182 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Antidiabetic 和 Prescription Medicine。
Compare with TopFind
实时搜索
正在加载实时结果
TopFind 正在为你的搜索抓取最新匹配结果。
实时搜索
TopFind 正在为你的搜索抓取最新匹配结果。
我们查看了 semi daonil 的 182 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Antidiabetic 和 Prescription Medicine。
来源: Sanofi-Aventis Singapore Pte Ltd
描述
Semi-Daonil is a lower-dose formulation of the antidiabetic drug Glibenclamide, containing 2.5 mg per tablet. This version is specifically designed for patients who require precise dose titration or a smaller maintenance dose to manage their Type 2 diabetes effectively without excessive risk of hypoglycemia.
适用场景
Dosage titration, Maintenance therapy 和 Type 2 diabetes control
评分
来源: Sanofi-Aventis Singapore Pte Ltd
描述
Daonil is a prescription-only oral antidiabetic medication containing 5 mg of Glibenclamide (a sulfonylurea). It is used for the management of Type 2 diabetes mellitus to help lower blood glucose levels by stimulating the pancreas to release more insulin. It is a long-standing treatment option registered with the Health Sciences Authority (HSA) and listed on the National Drug Formulary.
适用场景
Type 2 diabetes patients, Blood sugar management, Sulfonylurea therapy 和 Prescription medication
评分
来源: Sanofi-Aventis Singapore Pte Ltd
描述
Daonil M is a combination medication that integrates Glibenclamide with Metformin. This dual-action antidiabetic treatment targets Type 2 diabetes mellitus through two different mechanisms: increasing insulin production and improving the body's response to insulin, providing comprehensive glucose control in a single tablet.
适用场景
Dual Action glucose control, Combination therapy 和 Type 2 diabetes management
评分
| 比较 | Semi-Daonil | Daonil | Daonil M |
|---|---|---|---|
| 来源 | Sanofi-Aventis Singapore Pte Ltd | Sanofi-Aventis Singapore Pte Ltd | Sanofi-Aventis Singapore Pte Ltd |
| 描述 | Semi-Daonil is a lower-dose formulation of the antidiabetic drug Glibenclamide, containing 2.5 mg per tablet. This version is specifically designed for patients who require precise dose titration or a smaller maintenance dose to manage their Type 2 diabetes effectively without excessive risk of hypoglycemia. | Daonil is a prescription-only oral antidiabetic medication containing 5 mg of Glibenclamide (a sulfonylurea). It is used for the management of Type 2 diabetes mellitus to help lower blood glucose levels by stimulating the pancreas to release more insulin. It is a long-standing treatment option registered with the Health Sciences Authority (HSA) and listed on the National Drug Formulary. | Daonil M is a combination medication that integrates Glibenclamide with Metformin. This dual-action antidiabetic treatment targets Type 2 diabetes mellitus through two different mechanisms: increasing insulin production and improving the body's response to insulin, providing comprehensive glucose control in a single tablet. |
| 适用场景 | Dosage titration, Maintenance therapy 和 Type 2 diabetes control | Type 2 diabetes patients, Blood sugar management, Sulfonylurea therapy 和 Prescription medication | Dual Action glucose control, Combination therapy 和 Type 2 diabetes management |
| 操作 | |||
| 评分 |
如果你想先看最均衡的选择，我推荐：
"Semi-Daonil 来自 Sanofi-Aventis Singapore Pte Ltd."
我选择它是因为 Offers flexibility for healthcare providers to tailor dosage according to specific patient needs, especially during the early stages of treatment.